These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3097665)

  • 1. Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience).
    Cirkel U; Schweppe KW; Ochs H; Schneider HP
    Prog Clin Biol Res; 1986; 225():189-99. PubMed ID: 3097665
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of LHRH agonist therapy in the treatment of endometriosis (Dutch experience).
    Franssen AM; Kauer FM; Rolland R; Zijlstra JA; Willemsen WN; van 't Veen AJ
    Prog Clin Biol Res; 1986; 225():201-10. PubMed ID: 3097666
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.
    Minaguchi H; Uemura T; Shirasu K
    Prog Clin Biol Res; 1986; 225():211-25. PubMed ID: 3097667
    [No Abstract]   [Full Text] [Related]  

  • 4. A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the University of Southern California experience.
    Yee B
    Prog Clin Biol Res; 1986; 225():175-88. PubMed ID: 3097664
    [No Abstract]   [Full Text] [Related]  

  • 5. CA-125 monitored therapy with GnRH analogue of pelvic endometriosis.
    Negri P; Ricciardelli MA; Tomasi A; Grechi E; Fortini RM
    Acta Eur Fertil; 1992; 23(4):171-4. PubMed ID: 1343472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial results in the treatment of endometriosis with the LH-RH analog buserelin].
    Hardt W; Schmidt-Gollwitzer M; Schmidt-Gollwitzer K; Genz T; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):483-9. PubMed ID: 3093311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal changes in buserelin therapy].
    Fuchs U; Zwirner M
    Zentralbl Gynakol; 1989; 111(18):1236-40. PubMed ID: 2511705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis.
    Lemay A; Maheux R; Jean C; Faure N
    Prog Clin Biol Res; 1986; 225():157-73. PubMed ID: 3097663
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study].
    Schindler AE; Bühler K; Mettler L; Fuchs U; Cirkel U; Ochs H; Schweppe KW; Koch R
    Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):569-73. PubMed ID: 8001754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.
    Shaw RW; Matta W
    Clin Reprod Fertil; 1986 Oct; 4(5):329-36. PubMed ID: 3100012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patients.
    Franssen AM; Rolland R; Chadha DR; Willemsen WN; Vemer HM
    Eur J Obstet Gynecol Reprod Biol; 1986 Dec; 23(5-6):379-86. PubMed ID: 3100357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis.
    Lemay A; Maheux R; Faure N; Jean C; Fazekas AT
    Fertil Steril; 1984 Jun; 41(6):863-71. PubMed ID: 6427019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LH-RH agonist treatment of endometriosis.
    Lemay A; Maheux R; Quesnel G; Bureau M; Faure N; Mérat P
    Contrib Gynecol Obstet; 1987; 16():247-53. PubMed ID: 3121249
    [No Abstract]   [Full Text] [Related]  

  • 14. Uterine leiomyoma: treatment with LHRH agonist.
    Maheux R; Lemay A
    Prog Clin Biol Res; 1986; 225():297-311. PubMed ID: 3097669
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ovarian suppression by the GnRH analog buserelin in the treatment of endometriosis. Clinical, biochemical and pelviscopic studies].
    Raitz von Frentz M; Schweppe KW
    Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):634-9. PubMed ID: 2145192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine leiomyoma and LHRH agonist treatment. A preliminary report.
    Rolland R; Franssen AM; Willemsen WN; Corbey RS
    Prog Clin Biol Res; 1986; 225():313-20. PubMed ID: 3097670
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical reversible castration with D-Trp-6-LH-RH microcapsules for the treatment of endometriosis. Preliminary results in a series of 51 patients.
    Zorn JR; Soubrane O; Siboni O; Papageorgiou G
    Contrib Gynecol Obstet; 1987; 16():254-9. PubMed ID: 2961507
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences in the treatment of endometriosis with the LH-RH analog buserelin with special reference to the post-therapy course].
    Schmidt-Gollwitzer K; Schönegg W; von Holleben H; Hardt W; Nevinny-Stickel J
    Wien Med Wochenschr; 1988 Nov; 138(21):552-6. PubMed ID: 3144097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotrophin releasing hormone agonist suppressive treatment of ovarian function decreases serum LH-beta and bioactive LH but maintains elevated levels of LH-alpha.
    Lemay A; Lourdusamy M
    Clin Endocrinol (Oxf); 1991 Mar; 34(3):191-6. PubMed ID: 1709841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of endometriosis with gonadotropin releasing hormone agonist (buserelin).
    Sirimongkolkasem R; Rojanasakul A; Chailurkit LO
    J Med Assoc Thai; 1990 Feb; 73 Suppl 1():37-41. PubMed ID: 2112582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.